Objectives: Evaluating the efficacy of a topical potent antioxidant serum containing 15% L-Ascorbic Acid, Neohesperidin, Pycnogenol, tocopherol and Hyaluronic Acid in skin ageing signs of Brazilian subjects with clinical, instrumental and skin imaging assessment techniques
Introduction: Skin Aging is a process linked to chronological aging and exposome such aschronic UV exposure and pollution which both induce, among other effect, reactive oxygen species. Therefore, topical formulations which have strong antioxidant effect could counteract this process. The current formulation combines strong antioxidant ingredients such as 15% of L-Ascorbic Acid, Neohesperidin, Pycnogenol, tocopherol with fragmented Hyaluronic Acid to improve the extracellular matrix.
Materials / method: 40 female subjects 40 to 65 years old, with phototype II to IV, presenting wrinkles (frontal, glabellar and naslolabial folds) score ≥ 2 to 5 (from Skin Aging Atlas), and facial dark spots (excluding ephelides and melasma) and/or lentigo were included in the study. All of them were evaluated for clinical efficacy and safety. 20 of them underwent instrumental (Primos, Visia CR, Cutometer, Chroma Meter) and 16 skin imaging (Confocal). The evaluation were performed after 45 and 90 days of product use. The confidence interval considered in the comparative analysis between time-points was of 95%.
Results: A statistically significant improvement on skin ageing signs were observed at day 90: frontal, nasolabial and glabellar wrinkles improved by 23.9%, 22.7% and 19.1%. Similar results were observed for skin tone homogeneity, dark spots color intensity and hyperpigmentation which were confirmed by VISIA. Instrumental measures at day 90 demonstrated improvements of skin texture, depth and volume of wrinkles; skin firmness and elasticity; skin homogeneity; in thickness of the epidermis and of the stratum corneum; and the morphology of the dermis and stratum corneum. No adverse events were observed.
Conclusion: The topical potent antioxidant serum containing 15% L-Ascorbic Acid, Neohesperidin, Pycnogenol, tocopherol and Hyaluronic Acid demonstrated a clinically relevant efficacy on skin ageing conditions, with a good safety profile after 90 days of daily use.
利益冲突声明
您有否接受任何资金来支持研究这个主题?
是
请注明名称(个人,公司,学会等等): VICHY, L’Oreal, Paris, France.
您是否接受过关于这项研究的任何酬金或其他报酬?
是
请注明名称(个人,公司,学会等等): VICHY, L’Oreal, Paris, France.
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
否
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
否
这项工作的完成感谢以下机构的支持: VICHY, L’Oreal, Paris, France.